ViroMed Introduces Molecular Tests for Rapid Diagnosis of Respiratory Viruses Including Avian Flu
Real-time PCR Test Quickly Detects and Differentiates the H5N1 Avian Flu Strain from Other More Common Respiratory Virus Strains
ViroMed Laboratories, Inc., a subsidiary of Laboratory Corporation of America(R) Holdings (LabCorp(R),) announced the availability of a real-time polymerase chain reaction (PCR) test for the typing of influenza A strains, including the avian flu H5N1 strain. In addition to the influenza A typing assay, a real-time PCR test for three common respiratory pathogens, influenza A, influenza B and respiratory syncytial virus (RSV), is now offered. Both tests can be performed directly on respiratory samples or on culture viral isolates.
"The addition of these tests further enhances ViroMed's comprehensive respiratory pathogen test menu," noted Myla Lai-Goldman, M.D., Executive Vice President, Chief Scientific Officer and Medical Director of LabCorp. "These rapid molecular tests detect the presence of common influenzas and other respiratory pathogens, while providing specific typing information for strains such as the H5N1 avian flu strain. As flu season approaches and concerns about avian flu mount, the level of detailed information these tests provide will be useful for the surveillance and monitoring of influenza activity. Faster diagnosis also leads to appropriate and cost effective antiviral treatment sooner, and brings peace of mind to physicians and their patients by expeditiously identifying the cause."
The ViroMed laboratory has served as a testing center for antiviral drug resistance studies in influenza strains isolated globally. In addition to PCR-based assays, ViroMed also has the capabilities to detect respiratory pathogens using more traditional assays such as rapid and standard culture methods and antibody-based detection methods.
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.